Within our registry, all KIT D816Vmut patients, who had initially been diagnosed as myeloid neoplasms such as CMML, triple-negative MF, and others, in fact fulfilled the WHO-criteria for a diagnosis of SM-AHN. This evidence concerns the gene KIT and systemic mastocytosis.